A randomized phase II trial of sequential gemcitabine plus vinorelbine followed by gemcitabine plus Ifosfamide versus gemcitabine plus cisplatin in the treatment of chemonaive patients with stage III and IV non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Teodorescu, G
Ciuleanu, T
Grigorescu, A
Firoiu, E
Muresan, DR
机构：
[1] Eli Lilly SRL, Bucharest, Romania
[2] Cluj Oncol Inst, Cluj Napoca, Romania
[3] Bucharest Oncol Inst, Bucharest, Romania
[4] Targoviste Cty Hosp, Targoviste, Romania
[5] Oradea Cty Hosp, Oradea, Romania
来源：
LUNG CANCER | 2005年 / 49卷
关键词：
D O I：
10.1016/S0169-5002(05)81075-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S271 / S272
页数：2
相关论文
共 50 条
  • [1] A randomized phase II trial of sequential gemcitabine plus vinorelbine followed by gemcitabine plus ifosfamide versus gemcitabine plus cisplatin in the treatment of chemo-naive patients with stages III and IV non-small cell lung cancer (NSCLC)
    Grigorescu, Alexandru
    Ciuleanu, Tudor
    Firoiu, Elena
    Muresan, Delia Ruta
    Teodorescu, Gabriela
    Basson, Bruce R.
    LUNG CANCER, 2007, 57 (02) : 168 - 174
  • [2] Gemcitabine plus cisplatin versus gemcitabine plus vinorelbine in the treatment of advanced non-small cell lung cancer (NSCLC).
    Zhang, Y
    Zhang, L
    Li, N
    Xu, F
    Pan, ZK
    Guang, ZZ
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 702S - 702S
  • [3] Gemcitabine and cisplatin versus vinorelbine and cisplatin versus ifosfamide plus gemcitabine followed by vinorelbine and cisplatin versus vinorelbine and cisplatin followed by ifosfamide and gemcitabine in stage IIIB-IV non small cell lung carcinoma: a prospective randomized phase III trial of the Gruppo Oncologico Italia Meridionale
    Gebbia, V
    Galetta, D
    Caruso, M
    Verderame, F
    Pezzella, G
    Valdesi, M
    Borsellino, N
    Pandolfo, G
    Durini, E
    Rinaldi, M
    Loizzi, M
    Gebbia, N
    Valenza, R
    Tirrito, ML
    Varvara, F
    Colucci, G
    LUNG CANCER, 2003, 39 (02) : 179 - 189
  • [4] Vinorelbine plus cisplatin versus docetaxel plus gemcitabine in advanced non-small cell lung cancer: A phase III randomized trial
    Georgoulias, V.
    Ardavanis, A.
    Tsiafaki, X.
    Agelidou, A.
    Syrigos, K.
    Polyzos, A.
    Kakolyris, S.
    Kouroussis, Ch
    Androulakis, N.
    Chatzidaki, D.
    ANNALS OF ONCOLOGY, 2004, 15 : 169 - 169
  • [5] Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer:: a phase III randomized trial
    Zatloukal, P
    Petruzelka, L
    Zemanová, M
    Kolek, V
    Skricková, J
    Pesek, M
    Fojtu, H
    Grygárková, I
    Sixtová, D
    Roubec, J
    Horenková, E
    Havel, L
    Prusa, P
    Nováková, L
    Skácel, T
    Kuta, M
    LUNG CANCER, 2003, 41 (03) : 321 - 331
  • [6] Phase III study of pemetrexed plus cisplatin versus gemcitabine plus cisplatin in chemonaive patients with locally advanced or metastatic non-small cell lung cancer (NSCLC)
    Manegold, C.
    Digumarti, R.
    Zukin, M.
    de Marinis, F.
    Mellerngaard, A.
    Gandara, D.
    Simms, L.
    Kaiser, C.
    Blatter, J.
    Gatzemeier, U.
    EJC SUPPLEMENTS, 2007, 5 (06): : 9 - 9
  • [7] Phase III study of pemetrexed plus cisplatin versus gemcitabine plus cisplatin in chemonaive patients with locally advanced or metastatic non-small cell lung cancer (NSCLC)
    Scagliotti, Giorgio
    Purvish, Parikh
    von Pawel, Joachim
    Biesma, Bonna
    Vansteenkiste, Johan
    Manegold, Christian
    Simms, Lorinda
    Posther, Sugarman Katherine
    Obasaju, Coleman
    Blatter, Johannes
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S306 - S306
  • [8] Randomized, multicenter, phase II study of gemcitabine plus cisplatin versus gemcitabine plus carboplatin in patients with advanced non-small cell lung cancer
    Mazzanti, P
    Massacesi, C
    Rocchi, MBL
    Mattioli, R
    Lippe, P
    Trivisonne, R
    Buzzi, F
    De Signoribus, G
    Tuveri, G
    Rossi, G
    Di Lullo, L
    Sturba, F
    Morale, D
    Catanzani, S
    Pilone, A
    Bonsignori, M
    Battelli, T
    LUNG CANCER, 2003, 41 (01) : 81 - 89
  • [9] Vinorelbine plus cisplatin versus docetaxel plus gemcitabine in advanced non-small-cell lung cancer: A phase III randomized trial
    Georgoulias, V
    Ardavanis, A
    Tsiafaki, X
    Agelidou, A
    Mixalopoulou, P
    Anagnostopoulou, O
    Ziotopoulos, P
    Toubis, M
    Syrigos, K
    Samaras, N
    Polyzos, A
    Christou, A
    Kakolyris, S
    Kouroussis, C
    Androulakis, N
    Samonis, G
    Chatzidaki, D
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (13) : 2937 - 2945
  • [10] Gemcitabine plus vinorelbine in stage IIIB or IV non-small cell lung cancer (NSCLC):: a multicentre phase II clinical trial
    Palmeri, S
    Leonardi, V
    Gebbia, V
    De Bella, MT
    Ferraù, F
    Faillù, G
    Spatafora, M
    Valenza, R
    Di Vita, G
    Vitello, S
    Carroccio, R
    Sciortino, G
    Vaglica, M
    Accurso, V
    Agostara, B
    Licata, G
    LUNG CANCER, 2001, 34 (01) : 115 - 123
12345